Subclinical Cardiovascular System Changes in Obese Patients with Juvenile Idiopathic Arthritis

Table 5

Correlations (Spearman correlation coefficient—rho) between IMT, FMD, LVMi, SDS-BMI, and traditional cardiovascular risk factors and inflammatory markers in the study group.

	IMT	FMD	LVMi	SDS-BMI
BMI	rho = 0.51, 𝑃<0.001	rho = −0.30, 𝑃=0.001	rho = 0.38, 𝑃=0.001	rho = 0.89, 𝑃<0.001
SDS-BMI	rho = 0.45, 𝑃<0.001	rho = −0.30, 𝑃<0.001	rho = 0.43, 𝑃<0.001	—
HOMA	rho = 0.29, 𝑃<0.001	rho = −0.34, 𝑃<0.001	rho = 0.32, 𝑃=0.008	rho = 0.41, 𝑃=0.001
SBP	rho = 0.54, 𝑃<0.001	rho = −0.20, 𝑃=0.010	rho = 0.32, 𝑃=0.006	rho = 0.47, 𝑃<0.001
DBP	rho = 0.21, 𝑃=0.050	rho = −0.14, 𝑃=0.160	rho = 0.04, 𝑃=0.700	rho = 0.38, 𝑃=0.002
TC	rho = 0.03, 𝑃=0.700	rho = −0.10, 𝑃=0.300	rho = 0.09, 𝑃=0.400	rho = 0.27, 𝑃=0.03
LDL	rho = 0.01, 𝑃=0.800	rho = −0.13, 𝑃=0.190	rho = 0.06, 𝑃=0.600	rho = 0.05, 𝑃=0.6
HDL	rho = −0.36, 𝑃<0.001	rho = 0.21, 𝑃=0.030	rho = −0.25, 𝑃=0.030	rho = −0.35, 𝑃=0.01
TG	rho = 0.14, 𝑃=0.170	rho = −0.10, 𝑃=0.300	rho = 0.23, 𝑃=0.190	rho = 0.13, 𝑃=0.18
hsCRP	rho = 0.38, 𝑃<0.001	rho = −0.3, 𝑃=0.005	rho = 0.31, 𝑃=0.016	rho = 0.46, 𝑃<0.001
IL-6	rho = 0.35, 𝑃=0.001	rho = −0.34, 𝑃=0.001	rho = 0.08, 𝑃=0.400	rho = 0.36, 𝑃=0.006
TNF𝛼	rho = 0.36, 𝑃<0.001	rho = −0.36; 𝑃<0.001	rho = 0.33, 𝑃=0.009	rho = 0.02, 𝑃=0.8